Key facts
- Notable investors include Ernst Abbe University of Jena, Founders Bay, Sparkasse Jena, bm-t Beteiligungsmanagement Thuringen.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Perceptec
- ·The full record, as it builds
Funding rounds
No funding rounds for Perceptec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perceptec
Developer of vision care technology designed to modernize and digitize the optometry and ophthalmology sectors. The company offers a compact 3D display-based eye testing system with intuitive self-guided usability, rapid diagnostic workflows, and minimal spatial requirements, enabling optometrists, ophthalmologists, and vision care providers with fast, accessible, and scalable tools for detecting visual impairments without the need for specialist supervision.
- Sector
- Information Technology
- HQ
- Jena, Germany
- Founded
- 2022
- Employees
- 5
- Website
- perceptec.de/
- Ownership
- Privately Held (backing)
Perceptec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perceptec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perceptec in its N-PORT filings yet. We sweep new filings monthly.